A 2023 survey from the American Heart Association conducted by The Harris Poll, found that a majority (70%) of heart attack and stroke survivors are unaware that LDL cholesterol is commonly referred to as ‘bad cholesterol.’
FDA approves study of Versameb’s mRNA therapy in urinary incontinence – Pharmaceutical Technology
Share this article The Phase IIa study of the mRNA treatment is scheduled to start in the first half of 2024. Credit: valiantsin suprunovich via